Cervical neoplasia. Pathogenesis, diagnosis, and management

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Cervical neoplasia presents a significant health challenge for women living with HIV.
• Human Immunodeficiency Virus (HIV) infection is known to accelerate the progression of human papillomavirus (HPV)-related oncogenic events.
• The precise mechanisms underlying HIV's impact on HPV oncogenesis remain incompletely understood.

Purpose of the Study:

• To highlight the challenges in managing cervical neoplasia in HIV-infected women.
• To underscore the unreliability of current screening methods for this population.
• To emphasize the need for novel therapeutic strategies.

Main Methods:

• Review of existing literature on cervical neoplasia in HIV-infected women.
• Analysis of the efficacy of current screening and treatment modalities.
• Identification of emerging therapeutic approaches.

Main Results:

• Cytologic screening for cervical neoplasia demonstrates limited reliability in HIV-infected women.
• Standard treatment protocols for cervical neoplasia show reduced effectiveness in this demographic.
• Invasive cervical cancer carries a particularly poor prognosis among HIV-positive individuals.

Conclusions:

• Management of cervical neoplasia in HIV-infected women requires specialized approaches due to screening and treatment limitations.
• There is an urgent need for the development and investigation of innovative therapeutic modalities.
• Further research is crucial to improve outcomes for HIV-infected women at risk for cervical cancer.